Desq Long
Sign in

Company

OCULAR THERAPEUTIX, INC

OCUL · CIK 0001393434

SEC FORM 4
$87,363.36

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 11,984 shares at $7.29 per share.

Reporting Person Anderman Todd · Officer Title Chief Legal Officer · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001104659-26-115551 · filed 2026-10-13 · View filing →

SEC FORM 4
$76,626.45

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 10,869 shares at $7.05 per share.

Reporting Person Heier Jeffrey S. · Officer Title Chief Scientific Officer · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001104659-26-114080 · filed 2026-10-06 · View filing →

SEC FORM 4
$70,429.50

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 9,990 shares at $7.05 per share.

Reporting Person Kaiser Peter · Officer Title Chief Development Officer · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001104659-26-114081 · filed 2026-10-06 · View filing →

SEC FORM 4
$11,253.76

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 1,099 shares at $10.24 per share.

Reporting Person Notman Donald · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001104659-26-104727 · filed 2026-09-02 · View filing →

SEC FORM 4
$233,159.73

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 21,649 shares at $10.77 per share.

Reporting Person Dugel Pravin · Officer Title See Remarks · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001104659-26-101667 · filed 2026-08-26 · View filing →

SEC FORM 4
$35,530.88

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 3,296 shares at $10.78 per share.

Reporting Person Heier Jeffrey S. · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001104659-26-101670 · filed 2026-08-26 · View filing →

SEC FORM 4
$20,449.66

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 1,897 shares at $10.78 per share.

Reporting Person Nayak Sanjay · Officer Title Chief Strategy Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001104659-26-101671 · filed 2026-08-26 · View filing →

SEC FORM 4
$32,686.95

OCULAR THERAPEUTIX, INC (OCUL)

Sale of 3,035 shares at $10.77 per share.

Reporting Person Kaiser Peter · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001104659-26-101674 · filed 2026-08-26 · View filing →